Evidence review

Thymosin Alpha 1 for Post-Surgery: Immune Modulation Evidence Review

#peptide#matrix
bundle · json · system map · manifest

Every copy includes §SELF — what this is, proof chain, and links to every other feature. No context required.

§SELF — this page explains the system
## §SELF — miscsubjects (paste without context)

**Principle:** Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.

**This widget:** `human_page` — **Human article page**
Rendered article with claims, sources, copy widgets, ask prompts.
- **article slug:** `thymosin-alpha-1-post-surgery`
- **contains:** rendered article, copy widgets, claims, sources, ask prompts
- **how to use:** Use Copy for LLM or Copy system map — both paste without context.
- **read:** https://miscsubjects.com/a/thymosin-alpha-1-post-surgery

### Logical proof (verify each step)
1. Articles are voxel graphs of tiered claims, not prose blobs. → https://miscsubjects.com/api/articles/constitution
2. Claims link to hash-chained sources via source_ids. → https://miscsubjects.com/api/articles/thymosin-alpha-1-post-surgery/sources
3. Ask reads topology; ingest/claim append to ledger. → https://miscsubjects.com/api/protocol
4. Models queue growth: populate → collaborate → repair → reflex. → https://miscsubjects.com/api/protocol/grow
5. Graph proves its own shape (reflex) and $/claim (yield). → https://miscsubjects.com/graph.html?layer=reflex
6. Full feature index + _explain on every API response. → https://miscsubjects.com/api/articles/system-map

### Related features (explains other parts of the system)
- **bundle** — Paste-ready package: body + claims + sources + voxels + provenance + manifest + constitution. · https://miscsubjects.com/api/articles/thymosin-alpha-1-post-surgery/bundle?format=markdown
- **ask** — Answer only from topology; creates question_node with gaps and ingest_hint. · https://miscsubjects.com/api/articles/thymosin-alpha-1-post-surgery/prompts
- **topology** — Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER. · https://miscsubjects.com/api/articles/thymosin-alpha-1-post-surgery/topology

### Full index
- JSON: https://miscsubjects.com/api/articles/system-map
- Markdown: https://miscsubjects.com/api/articles/system-map?format=markdown

*Not medical advice. Tier-honest. Cite claim/source ids.*

What's breaking down

The body is always doing two things at once: breaking down (degeneration) and building back (regeneration). A condition persists when breakdown outruns repair. Most drugs used for symptoms suppress a signal (pain, acid, anxiety, inflammation) without fixing the tissue that caused the signal. Peptides in this ledger are studied for repair pathways: new blood vessels, repair-cell migration, nerve regrowth, gut lining, neural connections. This article maps one compound through that frame — what it is, how it is proposed to work, what evidence exists, and what people report.

Why Thymosin Alpha-1 might help you

  1. Therefore for you: If that layer is part of your problem, Thymosin Alpha-1 is discussed because it targets repair (tissue) — not because it masks pain.

How these fit together

Single-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.

  • Thymosin Alpha-1 → immune modulation

What the evidence actually shows

This is a count of what is in this ledger — not a claim about all research worldwide.

  • Scientific sources catalogued (PubMed, trials, reviews): 5
  • Claims tagged human evidence: 5
  • Claims tagged preclinical (animal/lab): 0
  • Claims tagged anecdotal: 2
  • Reddit posts catalogued: 1
  • X posts catalogued: 1
  • Other anecdote sources (YouTube, Instagram, etc.): 0
  • Total sources in chain: 7

Quantified confidence (this ledger): 0.76 / 1.00 — moderate — human claims present in ledger

Formula: human claims×0.12 + preclinical×0.04 + anecdote×0.015 + studies (capped). This is not clinical certainty — it measures how much graded evidence is catalogued here.

What scientists say

Thymosin α1 combined with XELOX improves immune function and reduces serum tumor markers in colorectal cancer patients after radical surgery (source s1)

180-patient human study post-CRC surgery showing immune and recurrence benefits.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

The efficacy and safety of thymosin α1 for sepsis (TESTS) (source s2)

Large 2025 RCT with no mortality benefit in sepsis.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

Comprehensive Review of the Safety and Efficacy of Thymosin Alpha 1 in Human Clinical Trials (source s3)

Broad human safety compilation.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

Effect of thymosin α1 on Immune response and organ function in acute aortic dissection surgery: PANDA II trial protocol (source s4)

Ongoing surgical recovery trial protocol.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

Thymosin alpha 1 – Reimagine its broader applications (source s5)

References resection survival data.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

What people say on Reddit

Peptide called Thymosin Alpha 1 is resolving my MCAS — Reddit, r/MCAS (source s6)

Example of non-surgical immune anecdotes dominant on Reddit.

What people say on X

X post on recovery after surgery — X (source s7)

Sparse promotional recovery mention.

---

Not medical advice. Counts and quotes are from this article's hash-chained ledger. Anecdote = real reports, not proof. Animal studies ≠ human proof.

Post-surgery recovery · condition map

Evidence map

Hover a node — its path lights up. Click to open the article.

Full map →
Evidence · 7 sources · swipe →chain a4c40321c20e · verify chain · provenance
Evidence ledger 7 · tier-ranked · API
human
A 2024 human study of 180 colorectal cancer patients post-radical surgery found Thymosin Alpha 1 plus XELOX improved immune function and lowered three-year recurrence vs XELOX alone.
sources: s1
human
A 2024 narrative review summarized safety and efficacy across over 11,000 human subjects in more than 30 trials involving Thymosin Alpha 1.
sources: s3
humanlow confidence
A 2025 phase 3 human trial of 1,106 sepsis patients found no significant 28-day mortality reduction with Thymosin Alpha 1 vs placebo (23.4% vs 24.1%).
sources: s2
humanlow confidence
PANDA II is an ongoing multicenter randomized human trial protocol testing Thymosin Alpha 1 after acute aortic dissection surgery for immune and organ function effects.
sources: s4
humanlow confidence
Propensity-matched human analyses in HBV-related HCC post-resection showed improved postoperative survival with Thymosin Alpha 1 adjuvant use.
sources: s5
2 more ranked claims
anecdotal0.22low confidence
Reddit anecdotes on Thymosin Alpha 1 primarily concern MCAS, CFS, or long COVID rather than specific post-surgical recovery.
grok/grok-4.3
Documents limited surgical-specific user reports.
sources: s6
anecdotal0.22low confidence
X posts mentioning Thymosin Alpha 1 in recovery contexts are sparse and mostly promotional.
grok/grok-4.3
Confirms low volume of relevant anecdotes.
sources: s7
Model swipes · 1 from 1 model · swipe →verify
1 / 1
grok/grok-4.3writer
redraft2026-06-29 22:59
Thymosin Alpha 1 for Post-Surgery: Immune Modulation Evidence Review · 7 claims · 7 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: Write a data-first, evidence-graded article: Thymosin Alpha 1 for Post Surgery
Slug: thymosin-alpha-1-post-surgery
Audience: readers researching peptide evidence for this specific condition or drug cross.
Rules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.

ENRICHMENT BRIEF (binding section logic — one ## per compound):
{"voice":"enrichment","article_shape":"single_focus","condition":null,"condition_key":null,"primary_peptide":null,"peptides_in_scope":[{"id":"thymosin-alpha-1","name":"Thymosin Alpha-1"}],"drugs_in_scope":[],"weight_sensitive":false,"stimulant_context":false,"breaking_down":{"section_title":"What's breaki
it output
{
  "slug": "thymosin-alpha-1-post-surgery",
  "title": "Thymosin Alpha 1 for Post-Surgery: Immune Modulation Evidence Review",
  "body": "## What's breaking down\n\nPost-surgery, the body experiences acute tissue trauma from incisions, tissue manipulation, and blood loss. This triggers a stress response that often suppresses certain immune functions while ramping up inflammation. T-cell activity can drop, natural killer cell function may decline, and the risk of postoperative infections rises because the immune system is temporarily dysregulated rather than fully coordinated for repair.\n\nIf immune balance does not recover promptly, tissue healing slows, hospital stays extend, and complications like wound infections or organ stress become more likely. The core issue is not just the wound itself but whether repair pathways outpace ongoing breakdown from inflammation and opportunistic pathogens. Thymosin Alpha 1 is discussed in this context for its studied effects on immune cell coordination, not as a pain mask or direct wound sealant.\n\n## Why Thymosin Alpha 1 might help you\n\nIf immune dysregulation after surgery is part of your situation, Thymosin Alpha 1 is examined because it targets immune restoration pathways that support tissue repair coordination. Here is the logic chain:\n\n1. Surgical trauma commonly reduces CD4+ T-cell counts and shifts immune balance toward suppr
5ee94409ef17f74b
Ask this article · 8 suggested prompts

Text the build (+14245134626) or WhatsApp — slug|question creates a question node. Paste evidence with ingest slug|q:NODE_ID|your paste.

What does the ledger say about this (human tier): "A 2024 human study of 180 colorectal cancer patients post-radical surgery found Thymosin Alpha 1 plus XELOX improved immune function and low…"?
ask thymosin-alpha-1-post-surgery claim c1 · paste includes §SELF
What does the ledger say about this (human tier): "A 2024 narrative review summarized safety and efficacy across over 11,000 human subjects in more than 30 trials involving Thymosin Alpha 1."?
ask thymosin-alpha-1-post-surgery claim c3 · paste includes §SELF
What does the ledger say about this (human tier): "A 2025 phase 3 human trial of 1,106 sepsis patients found no significant 28-day mortality reduction with Thymosin Alpha 1 vs placebo (23.4% …"?
ask thymosin-alpha-1-post-surgery claim c2 · paste includes §SELF
What does the ledger say about this (human tier): "PANDA II is an ongoing multicenter randomized human trial protocol testing Thymosin Alpha 1 after acute aortic dissection surgery for immune…"?
ask thymosin-alpha-1-post-surgery claim c4 · paste includes §SELF
What does the ledger say about this (human tier): "Propensity-matched human analyses in HBV-related HCC post-resection showed improved postoperative survival with Thymosin Alpha 1 adjuvant us…"?
ask thymosin-alpha-1-post-surgery claim c5 · paste includes §SELF
What does the ledger say about this (anecdotal tier): "Reddit anecdotes on Thymosin Alpha 1 primarily concern MCAS, CFS, or long COVID rather than specific post-surgical recovery."?
ask thymosin-alpha-1-post-surgery claim c6 · paste includes §SELF
Summarize this reddit report and how it should weigh: "Example of non-surgical immune anecdotes dominant on Reddit."
ask thymosin-alpha-1-post-surgery source s6 · paste includes §SELF
Summarize this x report and how it should weigh: "Sparse promotional recovery mention."
ask thymosin-alpha-1-post-surgery source s7 · paste includes §SELF
thymosin-alpha-1-post-surgery · posted 2026-06-29 · updated 2026-06-29 · 1 prior revision · grok/grok-4.3
Ledger API & provenance
Provenance · 1 model pass · 39372 tokens · $0 · 1 model
chain head f5fe9a04cda2ae34
write grok/grok-4.3 · 2026-06-29 22:59 · 39372 tok · f5fe9a04cda2
verify chain →
Live ledger · 6 payloads · 1 turn
recent activity · inspect
webhook_in blooio · 2026-06-29 22:59
webhook_in blooio · 2026-06-29 22:59
PROTOCOL_RUN dispatch · 2026-06-29 22:59 · t_gi8925tf
PROTOCOL_RUN dispatch · 2026-06-29 22:59 · t_gi8925tf
webhook_in blooio · 2026-06-29 22:59
webhook_in blooio · 2026-06-29 22:59
view full ledger & cards →
REST + ledger
read GET /api/articles/thymosin-alpha-1-post-surgery · GET /api/articles/thymosin-alpha-1-post-surgery?format=post (the editable body)
create/replace POST /api/articles/thymosin-alpha-1-post-surgery · PUT /api/articles/thymosin-alpha-1-post-surgery (replace, keeps revision) · PATCH /api/articles/thymosin-alpha-1-post-surgery (merge)
delete DELETE /api/articles/thymosin-alpha-1-post-surgery
writes need header x-terminal-key
LLM bundle GET /api/articles/thymosin-alpha-1-post-surgery/bundle?format=markdown — body + claims + sources + provenance + manifest
post claim POST /api/protocol/claim · iMessage claim thymosin-alpha-1-post-surgery|tier|assertion
system map GET /api/articles/system-map?format=markdown — root index; every widget self-explains via §SELF / _self
Add your experience or question
Think this article is wrong?
Call bullshit on CharlieOS →